356 related articles for article (PubMed ID: 8203435)
1. Gonadotropin-releasing hormone agonist use before hysterectomy.
Stovall TG; Summit RL; Washburn SA; Ling FW
Am J Obstet Gynecol; 1994 Jun; 170(6):1744-8; discussion 1748-51. PubMed ID: 8203435
[TBL] [Abstract][Full Text] [Related]
2. Myomectomy after selective preoperative treatment with a gonadotropin releasing hormone analog.
Hutchins FL
J Reprod Med; 1992 Aug; 37(8):699-702. PubMed ID: 1432986
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas.
Stovall TG; Ling FW; Henry LC; Woodruff MR
Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1420-3; discussion 1423-5. PubMed ID: 1904681
[TBL] [Abstract][Full Text] [Related]
4. GnRH agonists before surgery for uterine leiomyomas. A review.
Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
[TBL] [Abstract][Full Text] [Related]
5. Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas.
Saltiel E
Formulary; 1995 Sep; 30(9):532-4, 542. PubMed ID: 10161243
[TBL] [Abstract][Full Text] [Related]
6. Vaginal hysterectomy by uterine morcellation: an efficient, non-morbid procedure.
Mazdisnian F; Kurzel RB; Coe S; Bosuk M; Montz F
Obstet Gynecol; 1995 Jul; 86(1):60-4. PubMed ID: 7784024
[TBL] [Abstract][Full Text] [Related]
7. Does medical debulking with gonadotrophin-releasing hormone agonist facilitate vaginal hysterectomy with a moderate enlarged uterus? A randomized control study.
Elzaher MA; Moawad A; Madkour WA; Ali M; Salah Eldin Abdel Hamid AM; Zaheer H
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):326-30. PubMed ID: 23537617
[TBL] [Abstract][Full Text] [Related]
8. The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study.
Reinsch RC; Murphy AA; Morales AJ; Yen SS
Am J Obstet Gynecol; 1994 Jun; 170(6):1623-7; discussion 1627-8. PubMed ID: 8203418
[TBL] [Abstract][Full Text] [Related]
9. Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomas.
Iverson RE; Chelmow D; Strohbehn K; Waldman L; Evantash EG
Obstet Gynecol; 1996 Sep; 88(3):415-9. PubMed ID: 8752251
[TBL] [Abstract][Full Text] [Related]
10. [Usefulness of GnRH agonists in preoperative treatment of complicated uterine myomata].
Campusano C; Zapata R; Bianchi M; Badia JI; Arteaga E
Rev Chil Obstet Ginecol; 1993; 58(2):150-4. PubMed ID: 8209044
[TBL] [Abstract][Full Text] [Related]
11. Routine hysterectomy for large asymptomatic uterine leiomyomata: a reappraisal.
Reiter RC; Wagner PL; Gambone JC
Obstet Gynecol; 1992 Apr; 79(4):481-4. PubMed ID: 1553162
[TBL] [Abstract][Full Text] [Related]
12. Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy.
Mizutani T; Sugihara A; Honma H; Komura H; Nakamuro K; Terada N
Gynecol Endocrinol; 2005 Feb; 20(2):80-3. PubMed ID: 15823826
[TBL] [Abstract][Full Text] [Related]
13. GnRH analogue-induced uterine shrinkage enabling a vaginal hysterectomy and repair in large leiomyomatous uteri.
Schneider D; Golan A; Bukovsky I; Pansky M; Caspi E
Obstet Gynecol; 1991 Sep; 78(3 Pt 2):540-1. PubMed ID: 1831252
[TBL] [Abstract][Full Text] [Related]
14. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of leuprorelin acetate depot in symptomatic fibromatous uteri: the Italian Multicentre Trial.
Serra GB; Panetta V; Colosimo M; Romanini C; Lafuenti GB; Garcea N; Votano S; Agatensi L
Clin Ther; 1992; 14 Suppl A():57-73. PubMed ID: 1606594
[TBL] [Abstract][Full Text] [Related]
16. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas.
Wang PH; Lee WL; Cheng MH; Yen MS; Chao KC; Chao HT
Taiwan J Obstet Gynecol; 2009 Jun; 48(2):133-7. PubMed ID: 19574174
[TBL] [Abstract][Full Text] [Related]
17. Use of GnRH agonist before hysterectomy: a cost simulation.
Bradham DD; Stovall TG; Thompson CD
Obstet Gynecol; 1995 Mar; 85(3):401-6. PubMed ID: 7862380
[TBL] [Abstract][Full Text] [Related]
18. Vaginal hysterectomy and oophorectomy in women with 12-20 weeks' size uterus.
Sahin Y
Acta Obstet Gynecol Scand; 2007; 86(11):1359-69. PubMed ID: 17963064
[TBL] [Abstract][Full Text] [Related]
19. Presurgical treatment of uterine fibroids by using gonadotropin-releasing hormone agonists.
Falsetti L; Mazzani MD; Rubessa S; Ruggeri C
Acta Eur Fertil; 1992; 23(1):29-32. PubMed ID: 1293897
[TBL] [Abstract][Full Text] [Related]
20. Vaginal hysterectomy in generally considered contraindications to vaginal surgery.
Paparella P; Sizzi O; Rossetti A; De Benedittis F; Paparella R
Arch Gynecol Obstet; 2004 Sep; 270(2):104-9. PubMed ID: 12856131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
